25.31
Bakteriyel Patojenlere Karşı Savunma
İnsan bağışıklık sistemi, vücudu bakteriyel enfeksiyonlara karşı savunmak için birlikte çalışan karmaşık bir hücre, doku ve organ ağıdır. Her biri sav…
Patojenik bakterilere karşı bağışıklık savunması, adaptif sistemden gelen T ve B hücreleri ile birlikte doğuştan gelen makrofajlar gibi fagositleri içerir.
Bakteriyel patojenler genellikle ilk olarak non-spesifik ve fagositoz çeşitliliğine sahip bakteri hücreleri olan makrofajlarla karşılaşırlar.
Buna karşılık, B hücreleri sadece antijen reseptörlerine karşılık gelen spesifik bakteriyel antijenleri tanıyabilir ve içselleştirebilir.
Hem makrofajlar hem de B hücreleri, bakteriyel antijenleri işleyen ve bunları MHC moleküllerini kullanarak gösteren antijen sunan hücreler veya APC'lerdir.
Bu APC'ler, MHC II'ye bağlı antijenleri saf CD4 T hücrelerine sunar ve onları yardımcı T hücrelerine farklılaştırır.
Bu efektör hücreler sitokinleri serbest bırakarak B hücrelerini çoğalmaya ve antikor üreten plazma hücrelerine farklılaşmaya teşvik eder.
Antikor molekülleri, antijenlerle kompleksler oluşturur ve opsonizasyonu kolaylaştırır - bakteri hücrelerini antikorlarla kaplar - fagositik hücreler tarafından tanınmalarını ve alımlarını arttırır.
Tüberküloz gibi enfeksiyonlarda, enfekte hücreler MHC I ile kompleks antijenleri saf CD8 T hücrelerine sunar. Sitotoksik T hücrelerine farklılaşırlar ve enfekte olmuş hücreleri öldürürler.
View the full transcript and gain access to JoVE Core videos
Q1: How do macrophages and B cells differ in their recognition of bacterial pathogens?
Macrophages are non-specific phagocytes that recognize and engulf diverse bacterial cells without prior sensitization. B cells, by contrast, recognize only specific bacterial antigens corresponding to their unique antigen receptors. Both cells function as antigen-presenting cells, processing bacterial antigens and displaying them using MHC molecules to activate T cells.
Q2: What role do helper T cells play in the immune response against bacteria?
Helper T cells differentiate from naive CD4 T cells after antigen presentation by APCs. These effector cells release cytokines that stimulate B cells to proliferate and differentiate into antibody-producing plasma cells. Cytokines also enhance macrophage phagocytosis, amplifying the overall immune response against bacterial infections.
Q3: How does opsonization enhance bacterial clearance by the immune system?
Opsonization occurs when antibody molecules form complexes with bacterial antigens, coating the bacterial cell surface with antibodies. This antibody coating marks bacteria for destruction and significantly enhances their recognition and uptake by phagocytic cells like macrophages and neutrophils, accelerating bacterial clearance.
Q4: What is the immune response mechanism against intracellular bacterial infections?
When bacteria infect host cells, infected cells present bacterial antigens complexed with MHC I molecules to naive CD8 T cells. These cells differentiate into cytotoxic T cells, which recognize the presented antigens and kill infected cells by releasing cytotoxic molecules that induce apoptosis, eliminating the intracellular bacterial threat.
Q5: How do pathogenic bacteria like Mycobacterium tuberculosis evade immune destruction?
Mycobacterium tuberculosis has evolved intricate cell wall structures that resist the digestive enzymes within macrophage lysosomes, allowing the bacteria to survive intracellularly. This resistance enables the pathogen to persist and cause chronic infections. Such evasion mechanisms result from natural selection and evolutionary adaptation rather than conscious pathogen strategies.
Q6: Why does antibiotic resistance in bacteria like MRSA complicate immune defense?
Methicillin-resistant Staphylococcus aureus has developed resistance to multiple antibiotics, making infections difficult to treat. Additionally, different bacterial strains feature different surface antigens, so an immune response effective against one strain may not protect against another. This antigenic variation allows bacterial species to survive and adapt despite immune pressure.
Q7: How do macrophages eliminate resistant bacteria like Mycobacterium leprae?
When confronted with resistant bacteria, macrophages activated by cytokine signals from helper T cells engage specialized metabolic pathways involving oxidative metabolism. These pathways create an inhospitable environment for bacteria, often employing nitric oxide to eliminate the pathogen within the macrophage, overcoming lysosomal enzyme resistance.